Return to program book search

Session Information

SYM S013 - Systemic Therapies for Dermatologists: A Comprehensive Review and Update

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Friday, March 21

CME Credits: 3.00

Location: Room 102/104/106

Time: 2:00 PM - 5:00 PM

Director: J. Mark Jackson, MD, FAAD - Handout

Speakers:
  • Jeffrey Phillip Callen, MD, FAAD - Handout
  • Melissa I. Costner, MD, FAAD - Handout
  • David Franklin Fiorentino, MD, PhD, FAAD
  • Allan C. Halpern, MD, FAAD
  • Alexandra Boer Kimball, MD, MPH, FAAD
  • Sarbjit Saini, MD - Handout
  • Guy F. Webster, MD, PhD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Use current systemic therapies appropriately.
  • Monitor and manage the current systemic therapies
  • Utilize pearls and new information for each therapy to improve patient outcomes

Description:
This session is directed toward medical dermatologists and residents who are interested in learning how to best utilize, manage, monitor and administer the current systemic therapies available to treat dermatologic diseases, as well as for dermatologists looking to refresh and update their knowledge of systemic therapies. The session will cover chemotherapies, immunosuppressive, immunomodulators, anti inflammatory agents, systemic retinoids and the biologic agents. The goal will be to learn practical pearls as well as important scientific information for each therapy. The presenters are known for their expertise in the agents discussed.

Schedule:

Friday, March 21
2:00 PMIntroduction / Dr. Jackson
2:10 PMAzathioprine and Mycophenolate Mofetil / Dr. Callen
2:30 PMTNF Alpha Inhibitors and IL 12/23 Inhibitors / Dr. Kimball
2:50 PMQuestion and answer session / Dr. Jackson, Dr. Callen, and Dr. Kimball
3:00 PMMethotrexate and Cyclosporin / Dr. Costner
3:20 PMChemotherapeutics Vismodegib and Vemurafinib / Dr. Halpern
3:40 PMRetinoids: Acitretin and Isotretinoin / Dr. Webster
4:00 PMQuestion and answer session / Dr. Jackson, Dr. Halpern, Dr. Webster, and Dr. Costner
4:10 PMRituximab and Intravenous Immune Globlin / Dr. Fiorentino
4:30 PMOmalizumab / Dr. Saini
4:50 PMQuestion and answer session / Dr. Fiorentino and Dr. Saini